The Use of Lanreotide in the Treatment of Congenital Hyperinsulinism.
Heather CuffKatherine LordLance BallesterTryce ScullyNicole StewartDiva D De LeónPublished in: The Journal of clinical endocrinology and metabolism (2022)
Lanreotide is a well-tolerated treatment for patients with HI. It results in a longer duration of fasting and a simplification of treatment regimens.